Maria Horga Arantxa's most recent trade in Atea Pharmaceuticals Inc was a trade of 192,800 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 31, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Atea Pharmaceuticals Inc | Maria Arantxa Horga | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 192,800 | 192,800 | - | - | Stock Option (Right to Buy) | |
| Atea Pharmaceuticals Inc | Maria Arantxa Horga | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2025 | 41,533 | 41,533 | - | - | Restricted Stock Units | |
| Atea Pharmaceuticals Inc | Maria Arantxa Horga | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2025 | 41,533 | 67,197 | - | - | Common Stock | |
| Atea Pharmaceuticals Inc | Maria Arantxa Horga | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.06 per share. | 31 Jan 2025 | 16,071 | 60,876 | - | 3.1 | 49,177 | Common Stock |
| Atea Pharmaceuticals Inc | Maria Arantxa Horga | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 9,750 | 9,750 | - | - | Restricted Stock Units | |
| Atea Pharmaceuticals Inc | Maria Arantxa Horga | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 9,750 | 76,947 | - | - | Common Stock | |
| Atea Pharmaceuticals Inc | Arantxa Maria Horga | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 192,800 | 192,800 | - | - | Stock Option (Right to Buy) | |
| Atea Pharmaceuticals Inc | Maria Arantxa Horga | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 41,534 | 41,534 | - | - | Common Stock | |
| Atea Pharmaceuticals Inc | Maria Horga Arantxa | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 41,534 | 83,066 | - | - | Restricted Stock Units | |
| Atea Pharmaceuticals Inc | Arantxa Maria Horga | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 3.84 per share. | 31 Jan 2024 | 15,870 | 25,664 | - | 3.8 | 60,963 | Common Stock |
| Atea Pharmaceuticals Inc | Maria Arantxa Horga | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 174,500 | 174,500 | - | - | Stock Option (Right to Buy) | |
| Atea Pharmaceuticals Inc | Maria Arantxa Horga | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 124,600 | 124,600 | - | - | Restricted Stock Units | |
| Atea Pharmaceuticals Inc | Maria Arantxa Horga | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 170,000 | 170,000 | - | - | Stock Option (Right to Buy) | |
| Atea Pharmaceuticals Inc | Maria Arantxa Horga | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 145,500 | 145,500 | - | - | Stock Option (Right to Buy) |